The Filing Desk

Ginkgo Bioworks vs Maravai LifeSciences

Ginkgo Bioworks DNA · Maravai LifeSciences MRVI · Life Sciences Tools & Services

Maravai LifeSciences reported revenue of $186 million in fiscal 2025, about the same as Ginkgo Bioworks' $170 million in fiscal 2025. Ginkgo Bioworks' revenue fell 25.1% in its latest year, and Maravai LifeSciences' fell 28.3%. Ginkgo Bioworks had an operating margin of -185.3%, against -115.9% at Maravai LifeSciences. Free cash flow was −$179 million at Ginkgo Bioworks and −$71 million at Maravai LifeSciences.

Side by side

Ginkgo BioworksMaravai LifeSciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$170M$186M
Revenue growth−25.1%−28.3%
Revenue growth a year, last 5 years17.3%−8.2%
Gross margin—18.3%
Operating margin−185.3%−115.9%
Net margin−183.8%−70.4%
Free cash flow−$179M−$71M
Free cash flow margin−105.0%−38.1%
Return on capital—−32.0%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count6.9%4.7%
Last close$9.61$7.54
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Ginkgo BioworksMaravai LifeSciences
Operating margin
Percent of revenue
Ginkgo BioworksMaravai LifeSciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Ginkgo BioworksMaravai LifeSciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ginkgo Bioworks and Maravai LifeSciences pages.